218 related articles for article (PubMed ID: 25261293)
21. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
22. Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
Chen JC; Handley D; Elsaid MI; Fisher JL; Owusu-Brackett N; Azap L; Bhattacharyya O; Pawlik TM; Carson WE; Obeng-Gyasi S
J Surg Oncol; 2024 Jun; 129(7):1179-1186. PubMed ID: 38643486
[TBL] [Abstract][Full Text] [Related]
23. Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy.
Nelson C; Bai H; Neboori H; Takita C; Motwani S; Wright JL; Hobeika G; Haffty BG; Jones T; Goyal S; Moran MS
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e279-83. PubMed ID: 22672752
[TBL] [Abstract][Full Text] [Related]
24. Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
Byng D; Retèl VP; Schaapveld M; Wesseling J; van Harten WH;
Breast Cancer Res Treat; 2021 May; 187(1):187-196. PubMed ID: 33389397
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.
Withrow DR; Morton LM; Curtis RE; Schonfeld SJ; Berrington de González A
Breast Cancer Res Treat; 2017 Nov; 166(1):299-306. PubMed ID: 28744752
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the ductal carcinoma in situ between White Americans and Chinese Americans.
Kuang XW; Sun ZH; Song JL; Zhu Z; Chen C
Medicine (Baltimore); 2021 Jan; 100(3):e24136. PubMed ID: 33546026
[TBL] [Abstract][Full Text] [Related]
27. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
28. Racial and Ethnic Disparities in Outcomes After Breast-Conserving Therapy and Endocrine Therapy for DCIS: A Post-Hoc Analysis of the NSABP B-35 Randomized Clinical Trial.
Kantor O; King TA; Jones A; Glass C; Leonard SJ; Ogayo ER; Mayer EL; Chavez-MacGregor M; Newman LA; Freedman RA; Mittendorf EA
Ann Surg Oncol; 2023 Dec; 30(13):8404-8411. PubMed ID: 37777685
[TBL] [Abstract][Full Text] [Related]
29. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
30. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
Hausauer AK; Keegan TH; Chang ET; Clarke CA
Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
[TBL] [Abstract][Full Text] [Related]
31. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
32. Cancer Outcomes in DCIS Patients Without Locoregional Treatment.
Ryser MD; Weaver DL; Zhao F; Worni M; Grimm LJ; Gulati R; Etzioni R; Hyslop T; Lee SJ; Hwang ES
J Natl Cancer Inst; 2019 Sep; 111(9):952-960. PubMed ID: 30759222
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.
Bertrand KA; Bethea TN; Rosenberg L; Bandera EV; Khoury T; Troester MA; Ambrosone CB; Palmer JR
Breast; 2020 Feb; 49():108-114. PubMed ID: 31786415
[TBL] [Abstract][Full Text] [Related]
34. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2018 Feb; 167(3):787-795. PubMed ID: 29119353
[TBL] [Abstract][Full Text] [Related]
35. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
36. Long-term Surveillance of Ductal Carcinoma in Situ Detected with Screening Mammography versus US: Factors Associated with Second Breast Cancer.
Choi SH; Choi JS; Han BK; Ko EY; Ko ES; Park KW
Radiology; 2019 Jul; 292(1):37-48. PubMed ID: 31038406
[TBL] [Abstract][Full Text] [Related]
37. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
38. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
39. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
Borgquist S; Zhou W; Jirström K; Amini RM; Sollie T; Sørlie T; Blomqvist C; Butt S; Wärnberg F
BMC Cancer; 2015 Jun; 15():468. PubMed ID: 26062614
[TBL] [Abstract][Full Text] [Related]
40. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]